As of 2024-12-13, the Fair Value of PolyPeptide Group AG (PPGN.SW) is -4.33 CHF. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 27.95 CHF, the upside of PolyPeptide Group AG is -115.49%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | 25.74 | 31.33 | 47.26 | 7.77 | -51.44 | 12.13 |
| YoY growth | 8.05% | 21.75% | 50.82% | -83.56% | -762.29% | -153.05% |
| Market Cap (mil) | 921.89 |
| P/E | |
| Forward P/E |
| EPS | -0.87 |
| Avg earnings growth rate | -153.05% |
| TTM earnings | -28.56 |